Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Neurology|September 12, 2001
Vascular biology of thrombosis: platelet-vessel wall interactions and aspirin effectsF Catella-LawsonCoronary Artery Disease|February 1, 1997
Direct thrombin inhibitors in cardiovascular diseaseF Catella-LawsonThe American Journal of Medicine|February 15, 2001
Cyclooxygenase inhibition and thrombogenicityF Catella-Lawson, L J CroffordDiabetes Research and Clinical Practice|February 1, 1996
Oxidative stress and platelet activation in diabetes mellitusF Catella-Lawson, G A FitzGeraldCirculation|October 20, 1998
Oral delivery of anticoagulant doses of heparin. A randomized, double-blind, controlled study in humansR A Baughman, S C Kapoor, R K Agarwal, et al.Proceedings of the National Academy of Sciences of the United States of America|January 6, 1999
Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2B F McAdam, F Catella-Lawson, I A Mardini, et al.Journal of Cardiovascular Pharmacology|January 16, 1999
A randomized, placebo-controlled, crossover study of E5510 and aspirin in healthy volunteersM P Reilly, N Moran, E Meagher, et al.Blood|May 9, 2001
Effect of the Pl(A2) alloantigen on the function of beta(3)-integrins in plateletsJ S Bennett, F Catella-Lawson, A R Rut, et al.The New England Journal of Medicine|December 26, 2001
Cyclooxygenase inhibitors and the antiplatelet effects of aspirinF Catella-Lawson, M P Reilly, S C Kapoor, et al.The Journal of Pharmacology and Experimental Therapeutics|April 24, 1999
Effects of specific inhibition of cyclooxygenase-2 on sodium balance, hemodynamics, and vasoactive eicosanoidsF Catella-Lawson, B McAdam, B W Morrison, et al.Pageof 2